Test Validated to Predict Recurrence Risk and Radiation Therapy Benefit in Breast Cancer
A blinded validation in more than 400 women shows the test provides clearer guidance on recurrence risk and radiation therapy decisions.
Latest Articles
Editor's Top Picks
Blood Test Shows Obesity Speeds Alzheimer’s Development
A longitudinal study finds blood-based biomarkers more sensitive than PET scans in detecting obesity's impact on Alzheimer's pathology.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Foundation Medicine Reaches 100 Approved Companion Diagnostic Indications
The precision medicine company now has 57 approvals in the US and 43 in Japan for its FoundationOne CDx and FoundationOne Liquid CDx tests.
Equipment & Supply Spotlight
Co-Diagnostics to Present Portable PCR Platform with AI Integration
The presentation introduces the Co-Dx PCR platform and smartphone interface and discusses how Co-Dx is harnessing AI to minimize user error and improve outcomes in real-time point-of-care testing.
News, Know-How & Standards
Disease Detection & Understanding
Study Identifies Factors That Interfere with Cancer Detection in Liquid Biopsy
Research analyzing cell-free DNA fragmentation patterns in healthy individuals reveals physiological confounders that could improve test accuracy.
